Abstract
Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Current Organic Chemistry
Title: The Daphniphyllum Alkaloids
Volume: 13 Issue: 6
Author(s): Mei Dong, Man-Li Zhang, Qing-Wen Shi, Yu-Cheng Gu and Hiromasa Kiyota
Affiliation:
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Abstract: Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Export Options
About this article
Cite this article as:
Dong Mei, Zhang Man-Li, Shi Qing-Wen, Gu Yu-Cheng and Kiyota Hiromasa, The Daphniphyllum Alkaloids, Current Organic Chemistry 2009; 13 (6) . https://dx.doi.org/10.2174/138527209787847345
DOI https://dx.doi.org/10.2174/138527209787847345 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insect Peptides – Perspectives in Human Diseases Treatment
Current Medicinal Chemistry Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
Current Pharmaceutical Biotechnology Engineering of Plant Metabolism for Drug and Food
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
Anti-Cancer Agents in Medicinal Chemistry Current Therapeutic Paradigms in Glioblastoma
Reviews on Recent Clinical Trials Rheumatoid Arthritis: A Clinical Overview of New Diagnostic and Treatment Approaches
Current Topics in Medicinal Chemistry Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Current Pharmaceutical Design Spectral Imaging Technology - A Review on Skin and Endoscopy Applications
Recent Patents on Medical Imaging Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer
Current Pharmaceutical Design Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors
Medicinal Chemistry The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Control of Protein Synthesis in Malignant Transformation - the Role of eIF4E and the eIF4E Binding Proteins in the Regulation of Apoptosis
Current Cancer Therapy Reviews Screening of Potential Plant Compounds as Survivin Inhibitors and its Anti-Cancer Efficacy by Molecular Docking
Current Enzyme Inhibition The Application of Optical Technology in Microfluidic Systems
Current Proteomics Combined Anticancer Therapies: An Overview of the Latest Applications
Anti-Cancer Agents in Medicinal Chemistry